Lv4
548 积分 2024-01-20 加入
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials
12天前
已完结
Albiglutide for the treatment of type 2 diabetes mellitus
12天前
已完结
DTB Select: 7 | July 2014
20天前
已完结
GLP-1 receptor agonists in the treatment of diabetic non-alcoholic steatohepatitis patients
20天前
已完结
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
20天前
已完结
Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus
20天前
已完结
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
20天前
已完结
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes
20天前
已完结
Efficacy and safety of once‐weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: The AMPLITUDE‐D, AMPLITUDE‐L and AMPLITUDE‐S randomized controlled trials
20天前
已完结
皖公网安备34019202002308
